LH (Labcorp Holdings) Beneish M-Score: -2.59 (As of Jun. 25, 2026)


LH Labcorp Holdings Inc LH
79 GF Score
Price $266.41
GF Value $271.41
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Labcorp Holdings Beneish M-Score?

Labcorp Holdings LH +0.46% 79 Beneish M-Score is -2.59 as of Jun. 25, 2026. GuruFocus rates LH with a GF Score™ of 79/100 and a GF Value™ of $271.41 (Fairly Valued). The stock has 6 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Labcorp Holdings ranks worse than 50.77% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.59 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Labcorp Holdings's Beneish M-Score or its related term are showing as below:

LH' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.51   Max: -2.2
Current: -2.59

During the past 13 years, the highest Beneish M-Score of Labcorp Holdings was -2.20. The lowest was -2.87. And the median was -2.51.


Labcorp Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings Beneish M-Score Chart

Labcorp Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.68 -2.74 -2.61 -2.76 -2.51

Labcorp Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.72 -2.71 -2.65 -2.51 -2.59

LH vs DGX, MTD, ILMN: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Labcorp Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Beneish M-Score falls into.


LH
79GF Score
Labcorp Holdings Inc LH
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labcorp Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Labcorp Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0037+0.528 * 0.9673+0.404 * 0.9859+0.892 * 1.0734+0.115 * 0.9554
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9126+4.679 * -0.035427-0.327 * 1.0099
=-2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $2,451 Mil.
Revenue was 3537.6 + 3515.8 + 3563.5 + 3527.3 = $14,144 Mil.
Gross Profit was 1013.8 + 993.2 + 1025.1 + 1046.2 = $4,078 Mil.
Total Current Assets was $4,559 Mil.
Total Assets was $19,087 Mil.
Property, Plant and Equipment(Net PPE) was $3,066 Mil.
Depreciation, Depletion and Amortization(DDA) was $688 Mil.
Selling, General, & Admin. Expense(SGA) was $2,221 Mil.
Total Current Liabilities was $2,641 Mil.
Long-Term Debt & Capital Lease Obligation was $6,552 Mil.
Net Income was 277.8 + 164.7 + 261.1 + 237.9 = $942 Mil.
Non Operating Income was -12.4 + -136.4 + -10.2 + -36.8 = $-196 Mil.
Cash Flow from Operations was 191.5 + 614.2 + 387.2 + 620.6 = $1,814 Mil.
Total Receivables was $2,275 Mil.
Revenue was 3345.1 + 3329.4 + 3282 + 3220.9 = $13,177 Mil.
Gross Profit was 948 + 896.3 + 904.4 + 926.4 = $3,675 Mil.
Total Current Assets was $3,790 Mil.
Total Assets was $17,604 Mil.
Property, Plant and Equipment(Net PPE) was $3,091 Mil.
Depreciation, Depletion and Amortization(DDA) was $656 Mil.
Selling, General, & Admin. Expense(SGA) was $2,268 Mil.
Total Current Liabilities was $2,065 Mil.
Long-Term Debt & Capital Lease Obligation was $6,332 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2450.5 / 14144.2) / (2274.5 / 13177.4)
=0.173251 / 0.172606
=1.0037

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3675.1 / 13177.4) / (4078.3 / 14144.2)
=0.278894 / 0.288337
=0.9673

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4558.8 + 3065.5) / 19087.1) / (1 - (3789.7 + 3090.8) / 17603.8)
=0.600552 / 0.609147
=0.9859

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=14144.2 / 13177.4
=1.0734

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(655.8 / (655.8 + 3090.8)) / (687.6 / (687.6 + 3065.5))
=0.175039 / 0.183209
=0.9554

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2221.3 / 14144.2) / (2267.6 / 13177.4)
=0.157047 / 0.172083
=0.9126

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6552.4 + 2641) / 19087.1) / ((6331.6 + 2064.6) / 17603.8)
=0.481655 / 0.476954
=1.0099

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(941.5 - -195.8 - 1813.5) / 19087.1
=-0.035427

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Labcorp Holdings has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.59 mean?
Labcorp Holdings (LH) has a Beneish M-Score of -2.59 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Labcorp Holdings and its competitors. According to the industry distribution chart, Labcorp Holdings ranks #99 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 50.8%.
Is Labcorp Holdings' Beneish M-Score too high?
Labcorp Holdings' current Beneish M-Score is -2.59. Based on the distribution chart, Labcorp Holdings ranks #99 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Beneish M-Score compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #99 out of 195 companies for Beneish M-Score. This places Labcorp Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Beneish M-Score is -2.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LH) is currently considered Fairly Valued. The stock's GF Value™ is $271.41, compared to a current price of $266.41 — trading 1.8% below its estimated fair value. The current Beneish M-Score is -2.59. Labcorp Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Labcorp Holdings (LH), the current Beneish M-Score is -2.59 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LH) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be undervalued. The current stock price of $266.41 is trading 1.8% below its estimated GF Value™ of $271.41. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LH:

  • Beneish M-Score: -2.59
  • GF Value™: $271.41 vs. price of $266.41 (1.8% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the LH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labcorp Holdings Business Description

Other Exchanges 0JSY:UKN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
79GF Score

Get the complete analysis for LH

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$266.41
Price
$271.41
GF Value